Development of a CRISPR/Cas9-degron system that enables in vivo specific gene depletion in leukemia models. Shimura R, Yamamoto K, Chang YH, Otaki A, et al. Biochem Biophys Res Commun 2025;793:153002.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Shimura R, Yamamoto K, Chang YH, Otaki A, et al. Development of a CRISPR/Cas9-degron system that enables in vivo specific gene depletion in leukemia models. Biochem Biophys Res Commun 2025;793:153002.
PMID: 41274245